Show simple item record

Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies

dc.contributor.authorLiu, Peipei
dc.contributor.authorMcMenamin, Úna C.
dc.contributor.authorJohnston, Brian T.
dc.contributor.authorMurchie, Peter
dc.contributor.authorIversen, Lisa
dc.contributor.authorLee, Amanda
dc.contributor.authorVissers, Pauline A. J.
dc.contributor.authorCardwell, Chris R.
dc.date.accessioned2020-11-05T00:07:23Z
dc.date.available2020-11-05T00:07:23Z
dc.date.issued2020-07-21
dc.identifier159933594
dc.identifier05e1d064-1fdd-43ec-810f-3328794b5b1a
dc.identifier000530221800001
dc.identifier32367073
dc.identifier85085099070
dc.identifier.citationLiu , P , McMenamin , Ú C , Johnston , B T , Murchie , P , Iversen , L , Lee , A , Vissers , P A J & Cardwell , C R 2020 , ' Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies ' , British Journal of Cancer , vol. 123 , pp. 307-315 . https://doi.org/10.1038/s41416-020-0860-4en
dc.identifier.issn0007-0920
dc.identifier.otherSCOPUS: 85085099070
dc.identifier.otherORCID: /0000-0001-9968-5991/work/83704268
dc.identifier.urihttps://hdl.handle.net/2164/15320
dc.descriptionAcknowledgements Access to UK Biobank data was approved and facilitated by UK Biobank (application number: 34374). Access to Primary Care Clinical Informatics Unit (PCCIU) data was approved and facilitated by the PCCIU Research team, University of Aberdeen. Access to the UK Biobank was funded by a Cancer Research UK Population Research Postdoctoral Fellowship awarded to ÚCMcM. Funding: Access to the UK Biobank was funded by a Cancer Research UK Population Research Postdoctoral Fellowship awarded to ÚCMcM. Liu P was supported by a joint scholarship from Queen's University Belfast and the Chinese Scholarship Council (201708060458). Data availability: The UK Biobank data (https://www.ukbiobank.ac.uk/) and PCCIU data (https://www.abdn.ac.uk/iahs/research/primary-care/pcciur/) are available, following the access procedures, for researchers to access to conduct health related research in the public interest.en
dc.format.extent9
dc.format.extent664063
dc.language.isoeng
dc.relation.ispartofBritish Journal of Canceren
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectACID-SUPPRESSIVE DRUGSen
dc.subjectLAG-TIMEen
dc.subjectASSOCIATIONen
dc.subjectESOPHAGEALen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectOncologyen
dc.subjectCancer Researchen
dc.subjectCancer Research UKen
dc.subjectSupplementary Dataen
dc.subject.lccRC0254en
dc.titleUse of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studiesen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Statisticsen
dc.description.statusPeer revieweden
dc.identifier.doi10.1038/s41416-020-0860-4
dc.date.embargoedUntil2020-11-05
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85085099070&partnerID=8YFLogxKen


Files in this item

Thumbnail
Name:
Liu_et_al_BJC_UseOfProtonPumpI ...
Size:
648.4Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record